This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Albany Molecular Research Inc (AMRI)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 49.34M 46.99M 175.93M 23.29M
Receivables 122.03M 76.70M 59.74M 50.68M
Inventories 89.23M 49.88M 31.99M 28.22M
Other Current Assets 516.00K 0.00 0.00 0.00
Total Current Assets 280.25M 191.01M 279.02M 113.42M
Property, Plant & Equipment, Gross 419.45M 352.51M 294.76M 294.49M
Accumulated Depreciation & Depletion 209.94M 187.03M 166.99M 158.97M
Property, Plant & Equipment, Net 209.51M 165.47M 127.78M 135.52M
Intangibles 120.20M 32.55M 3.04M 3.06M
Other Non-Current Assets 79.80M 64.26M 33.38M 7.33M
Total Non-Current Assets 585.32M 328.94M 166.25M 149.44M
Liabilities & Shareholder Equity
Total Assets 865.57M 519.95M 445.27M 262.86M
Accounts Payable 57.93M 32.16M 24.18M 18.19M
Short Term Debt 15.59M 447.00K 1.02M 776.00K
Other Current Liabilities 2.96M 677.00K 12.70M 11.64M
Total Current Liabilities 99.10M 48.69M 43.90M 35.99M
Long Term Debt 373.69M 159.98M 123.14M 7.23M
Deferred Income Taxes 0.00 0.00 631.00K 753.00K
Other Non-Current Liabilities 105.56M 69.46M 31.90M 12.76M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 479.25M 229.44M 155.66M 20.73M
Total Liabilities 578.34M 278.13M 199.56M 56.72M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 287.22M 241.82M 245.70M 206.14M
Common Par 411.00K 381.00K 370.00K 363.00K
Additional Paid In Capital 296.34M 243.87M 235.81M 207.78M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 77.33M 79.63M 87.86M 75.18M
Treasury Stock -68.45M -67.63M -67.05M -66.89M
Other Equity Adjustments -18.40M -14.43M -11.28M -10.29M
Total Capitalization 660.91M 401.80M 368.84M 213.37M
Total Equity 287.22M 241.82M 245.70M 206.14M
Total Liabilities & Stock Equity 865.57M 519.95M 445.27M 262.86M
Total Common Shares Outstanding 35.62M 32.63M 31.60M 30.91M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 5.51M 5.46M 5.42M 5.41M
Basic Weighted Shares Outstanding 33.17M 31.53M 30.91M 30.32M
Diluted Weighted Shares Outstanding 33.17M 31.53M 30.91M 30.32M
Number of Employees 2220 1668 1282 1329
Number of Part-Time Employees 0 0 0 0
AMRI News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

AMRI Albany Molecular Research Inc

Chart of AMRI

Analysts Ratings for AMRI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET AMRI ANALYST REPORT

AMRI Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs